Form 8-K · Current Report · Filed 2025-11-05
Metsera Responds to Pfizer Litigation Ruling
On November 5, 2025, Metsera, Inc. issued a statement in response to a ruling in the litigation filed against the Company by Pfizer Inc. The Delaware Court of Chancery denied Pfizer's request for a temporary restraining order, allowing Metsera's Board of Directors to act in the best interests of shareholders. Metsera remains resolute in standing firm on behalf of shareholders and patients.
- Filer
- MTSR MTSR
- Filed
- Accession
- 0001193125-25-267573
- CIK
- 0002040807
- Signal
- High impact
- Source
- Official filing on sec.gov ↗
Items reported
Other Events
Financial Statements and Exhibits
Market reaction
Close before filing
$73.18
Next session
+11.4%
Since filing
-3.7%
Latest close
$70.50
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from MTSR reporting the same item, with the next session's move:
Never miss another MTSR filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.